Guide for Parents: Preparing for your travel clinic appointment
FDA accepts NDA for berotralstat in HAE patients aged 2 to 11 years
The federal agency provided BioCryst Pharmaceuticals a target action date of September 12, 2025 for potential approval of berotralstat (ORLADEYO).
Food Insecurity and the Dangers of Infant Formula Dilution
FDA starts review of nutrients in infant formula
According to the agency, it is seeking public input to "determine whether existing nutrient requirements should be revised based on latest scientific data."
Demystifying Infant Formula
Maternal avocado consumption linked to reduced infant food allergy risk
Maternal avocado consumption during pregnancy was linked to significantly lower odds of infant food allergy at 12 months.
FDA clears EN-374 therapy application for X-linked chronic granulomatous disease
The in vivo hematopoietic stem cell-directed therapy received rare pediatric disease and orphan drug designations earlier this year.
